Empowering precision therapeutics with comprehensive genomic insights
Partner with us to gain the most complete view of the genetics of your disease of interest to drive informed decision-making throughout the entire drug development life cycle.
Leverage our expertise to build a complete, reliable foundation of evidence prior to entering the most expensive and time-consuming phases of drug development.
Target and Indication Selection
Enhance your confidence in the targets and indications you select with customizable, thorough reports that answer your most pressing questions, including the extent of existing preclinical work, the characteristics of your target patient population, and more.
Indication Expansion
Expand indications for existing targeted therapeutics based on complete evidence with a customizable, thorough evaluation of the applicable pathway, mechanism, related indications, and more.
Market Assessment
Genomenon’s evidence-based disease prevalence estimates inform market assessment. This data helps pharmaceutical companies understand the patient population and potential market size.
Leverage our expertise and leading software to ensure rapid access to the evidence you need to progress your program through clinical development.
Trial Eligibility and CDx
Expand and refine your inclusion criteria and companion diagnostics, and speed trial enrollment through rapid access to complete genetic evidence.
Genotype-Phenotype Analysis
Strengthen your understanding of genotype-phenotype correlations and enhance your trial design with complete knowledge of published patients alongside their demographics, clinical presentation, and full genotype.
Diagnostic Yield and Awareness
Enhance diagnostic yield and awareness of your disease of interest by granting our network of 2000+ clinical labs access to expertly-curated evidence that accelerates and ensures the completeness of genetic test results.
Genetic Disease Sponsorship - Leverage our expansive network to enhance diagnostic yield and continue to build awareness, even beyond approval.
Enhance Diagnostic Yield and Awareness
Enhance diagnostic yield and awareness of your disease of interest by granting our network of 2,000+ clinical labs access to expertly-curated evidence that accelerates and ensures the completeness of genetic test results.
Research & Development
Preclinical & Phase 1
Phase 2-3
Post Market
Impacting Top Research Institutions and Hospitals
Trusted by Industry Leaders Including
Our Offerings For Precision Therapeutics
Find out how we can help your organization.
